CONOCOPHILLIPS
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $58.9B | $54.7B | $56.1B | $78.5B | $45.8B |
| Cost of revenue | $22.3B | $20.0B | $22.0B | $34.0B | $18.2B |
| Selling, general & administrative | $893.0M | $1.2B | $705.0M | $623.0M | $719.0M |
| Research and development | $78.0M | $81.0M | $81.0M | $71.0M | $62.0M |
| Interest expense | $855.0M | $783.0M | $780.0M | $805.0M | $884.0M |
| Pretax income | $12.7B | $13.7B | $16.3B | $28.2B | $12.7B |
| Income tax expense | $4.7B | $4.4B | $5.3B | $9.5B | $4.6B |
| Net income | $8.0B | $9.2B | $11.0B | $18.7B | $8.1B |
| Balance Sheet | |||||
| Cash and equivalents | $6.5B | $5.6B | $5.6B | $6.5B | $5.0B |
| Current assets | $15.5B | $15.6B | $14.3B | $18.7B | $16.1B |
| Total assets | $121.9B | $122.8B | $95.9B | $93.8B | $90.7B |
| Current liabilities | $12.0B | $12.1B | $10.0B | $12.8B | $12.0B |
| Total liabilities | $57.5B | $58.0B | $46.6B | $45.8B | $45.3B |
| Stockholders' equity | $64.5B | $64.8B | $49.3B | $48.0B | $45.4B |
| Cash Flow Statement | |||||
| Cash from operations | $19.8B | $20.1B | $20.0B | $28.3B | $17.0B |
| Depreciation and amortization | $11.5B | $9.6B | $8.3B | $7.5B | $7.2B |
| Stock-based compensation | $336.0M | $268.0M | $334.0M | $377.0M | $304.0M |
| Capital expenditure | — | — | — | $10.2B | $5.3B |
| Free cash flow | — | — | — | $18.2B | $11.7B |
| Dividends paid | $4.0B | $3.6B | $5.6B | $5.7B | $2.4B |
| Share repurchases | $5.0B | $5.5B | $5.4B | $9.3B | $3.6B |
| Impairments | $26.0M | $80.0M | $14.0M | $12.0M | $674.0M |
Shares outstanding 1.2B · Free float 61.1%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.